Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope Share
CLICK HERE TO SHARE YOUR STORY!
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
Menu
  • About
    • Meet Our Contributors
    • Meet Our Partners
    • Meet the Patient Worthy Team
    • Collaborative Content On Patient Worthy
  • Diseases
  • Share Your Story
    • Patient Worthy Content Submission Guidelines
    • Patient Worthy Writing Prompts
    • Submit Your Story
    • Patient Stories
  • Resources
    • Library
    • Events
    • Patient Worthy FAQs
  • Podcast
  • Contact
  • Join PW

Daily Archives: June 13, 2022

  1. Home>
  2. 2022>
  3. June>
  4. 13
A Car Crash Saved the Life of a Woman with a Thymoma
https://pixabay.com/en/cuba-oldtimer-old-car-forest-red-1197800/

A Car Crash Saved the Life of a Woman with a Thymoma

  • Post author:Jessica Lynn
  • Post published:June 13, 2022
  • Post category:Rare Disease/Thymic epithelial tumor

It is very rare that one might say that a car accident saved their life – but Yolanda Carusciello, who lives in Brooklyn, can say just that. Of course, when…

Continue Reading A Car Crash Saved the Life of a Woman with a Thymoma
Study of the Week: Spinal Muscular Atrophy Type 3 Linked to Cognitive Impairments
source: pixabay.com

Study of the Week: Spinal Muscular Atrophy Type 3 Linked to Cognitive Impairments

  • Post author:James Moore
  • Post published:June 13, 2022
  • Post category:Spinal Muscular Atrophy

Welcome to Study of the Week from Patient Worthy. In this segment, we select a study we posted about from the previous week that we think is of particular interest…

Continue Reading Study of the Week: Spinal Muscular Atrophy Type 3 Linked to Cognitive Impairments
Mitapivat Beneficial for PKD, Study Shows
Photo courtesy of Towfiqu Barbhuiya on Unsplash

Mitapivat Beneficial for PKD, Study Shows

  • Post author:Jessica Lynn
  • Post published:June 13, 2022
  • Post category:Pyruvate kinase deficiency

Earlier this year, the U.S. Food and Drug Administration (FDA) approved mitapivat (PYRUKYND) for the treatment of patients with hemolytic anemia due to pyruvate kinase deficiency (PKD). According to 2…

Continue Reading Mitapivat Beneficial for PKD, Study Shows
Severe Atopic Dermatitis Could Heighten Non-Hodgkin Lymphoma Risk
source: pixabay.com

Severe Atopic Dermatitis Could Heighten Non-Hodgkin Lymphoma Risk

  • Post author:Jessica Lynn
  • Post published:June 13, 2022
  • Post category:Cancer/Severe Atopic Dermatitis

This year, the American Academy of Dermatology (AAD) Annual Meeting took place from March 25-29, 2022. During the meeting, researchers and stakeholders discussed trends and research within the field of…

Continue Reading Severe Atopic Dermatitis Could Heighten Non-Hodgkin Lymphoma Risk
An Overview of Chronic Lymphocytic Leukemia (CLL)
source: pixabay.com

An Overview of Chronic Lymphocytic Leukemia (CLL)

  • Post author:Rose Duesterwald
  • Post published:June 13, 2022
  • Post category:Rare Disease

  Leukemia, in general terms, is a form of cancer that affects the bone marrow and blood cells. According an article in Medical News Today, leukemia is categorized in accordance…

Continue Reading An Overview of Chronic Lymphocytic Leukemia (CLL)
Join in On Celebrating Dravet Syndrome Awareness Month!

Join in On Celebrating Dravet Syndrome Awareness Month!

  • Post author:Kendall Mason
  • Post published:June 13, 2022
  • Post category:Dravet Syndrome

During this month, the Dravet Syndrome Foundation (DSF) organizes a variety of activities and resources to help raise awareness for Dravet syndrome, a rare form of epilepsy. They make it…

Continue Reading Join in On Celebrating Dravet Syndrome Awareness Month!
Finding Light Through Story-The Power of Ambassadorship in the Endometrial Cancer Community
*cancer that cannot be removed with surgery or has spread to other parts of the body. GEJ= gastroesophageal junction (where the esophagus joins the stomach)
CLICK HERE TO SHARE YOUR STORY!
We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.
Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Partner With Us
Submit a Story

Keep Up to Date

Subscribe to Our Newsletter
Check Out Rare Events
Get Inspired By Our Memes

Learn More

About Us
Rare Diseases and Conditions
Terms of Use
Privacy Notice
Privacy Policy for CA Residents
EU/UK Privacy Notice
Data Privacy Framework: Consumer Privacy Policy
Consumer Health Data Privacy Policy
Cookie Notice

Facebook-f Twitter Instagram Podcast Youtube Tiktok Linkedin-in Pinterest Envelope

© Copyright 2024 Patient Worthy

Sign Up With a Patient Worthy Account and Share Your Rare Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info

We're Happy You're Here!

What best describes you when it comes to rare disease? (check all that apply)

What rare disease(s)/conditions are most important to you?

Visit Home Page or

Thank you for signing up for a Patient Worthy Account!

Have a rare disease story to share? Let us know

Share Story

- OR -

Sign Up For Our Patient Panel

Make a difference, share your experiences and get paid. Opt-in and join Patient Worthy's panel for paid opportunities such as surveys, market research, patient advisory panels and more.

More Info